The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg-Reference-Cited by-同舟云学术

The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg

Published:1988-07 Issue:7 Volume:28 Page:609-618
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Frydman A. M.,Bara L.,Roux Y. He,Woler M.,Chauliac F.,Samama M. M.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1988.tb03184.x/fullpdf

Reference48 articles.

1. Anticoagulant properties of heparin fractionated by affinity chromatography and gel filtration;Anderson;Thromb Res,1976

2. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4;Lane;Biochem J,1984

3. Anticoagulant activities of four unfractionated and fractionated heparins;Lane;Thromb Res,1978

4. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously;Bergqvist;Thromb Res,1983

5. Pharmacokinetics of a low molecular weight heparin as compared to conventional heparins in humans;Bratt;Thromb Haemost,1983

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐factor X activity levels with continuous intravenous infusion and subcutaneous administration of enoxaparin after coronary artery bypass grafting: A randomized clinical trial;Acta Anaesthesiologica Scandinavica;2022-08-12

2. Anticoagulation on Extracorporeal Support: An Alternative Strategy;ASAIO Journal;2022-07-07

3. Heparin: The Journey from Parenteral Agent to Nasal Delivery;Seminars in Thrombosis and Hemostasis;2022-06-22

4. Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19;Journal of Molecular Medicine;2022-03-26

5. Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults;Int. Journal of Clinical Pharmacology and Therapeutics;2021-11-01